Skip to search.
 FTSE 100 Up 0.04%

More On OXB.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Oxford BioMedica PLC (OXB.L)

-LSE Ticker: 664815/ISIN: GB0006648157
5.52 Down 0.53(8.76%) 28 Apr 16:35
Prev Close:6.05
Open:6.00
Bid:5.51 x 500000
Ask:5.53 x 1000000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:5.30 - 6.12
52wk Range:5.00 - 12.03
Volume:1,041,014
Avg Vol (3m):2,454,960
Market Cap:141.74m
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,170.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.56
Quarterly EPS Est (Dec-15) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines. Its LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple ther... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback